BRIEF

on AMOEBA (EPA:ALMIB)

Amoéba and Koppert extend their collaboration on biofungicides

Stock price chart of AMOEBA (EPA:ALMIB) showing fluctuations.

Amoéba, a specialist in microbiological solutions, and its partner Koppert, a leader in biological crop protection, have extended their distribution agreement for another year, until June 2031. This extension concerns the innovative biofungicide AXPERA, applicable to vines and vegetable crops, which is already authorized in France. The agreement covers 18 European countries and the United States.

Koppert recently demonstrated its commitment to promoting TIAGAN and YAZU products at trade shows like GreenTech Europe. The first order placed in March foreshadowed this acceleration.

With marketing authorization already obtained in France, this partnership promotes access to environmentally friendly biological solutions for farmers.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AMOEBA news